arbekacin has been researched along with pazufloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, Y; Kizawa, K; Miyazaki, M; Nagai, A; Nagasawa, M; Ogake, N; Sanzen, T | 1 |
| Hanaki, H; Matui, H; Oishi, T; Sunakawa, K; Uehara, K; Yamaguchi, Y; Yanagisawa, C | 1 |
2 other study(ies) available for arbekacin and pazufloxacin
| Article | Year |
|---|---|
[Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesilate].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dibekacin; Drug Interactions; Drug Therapy, Combination; Fluoroquinolones; Kidney Cortex; Kidney Diseases; Kidney Tubules; Male; Oxazines; Rats; Rats, Sprague-Dawley | 2003 |
[Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)].
Topics: Aminoglycosides; beta-Lactams; Dibekacin; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; In Vitro Techniques; Methicillin Resistance; Minocycline; Oxazines; Staphylococcus aureus; Teicoplanin; Vancomycin Resistance | 2005 |